Although IL-6 did not influence the PMCA2 level that can be decreased by IL-1β [65], the anti-IL-6 receptor antibody MR16-1 could decrease mechanical allodynia by inhibiting microglial activation and proliferation in the spinal cord of female MS mice [88]. This evidence concerns the gene IL6 and myeloid sarcoma.